New cyclospora, peptide panel, autism: Morning Rounds

AI Briefing

• – • Peptide panel approved, a win for advocates seeking personalized treatment for various health conditions.
• – • Autism advisory committees disagree on approach to addressing growing number of cases, with differing treatment recommendations.
• – • Cyclospora outbreak reported in several states, with new cases and clusters identified, prompting health officials to investigate.